DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes CareZacks Investment Research • 10/02/26
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes CareBusiness Wire • 09/28/26
DexCom, Inc. (DXCM) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?Zacks Investment Research • 08/12/26
Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?Zacks Investment Research • 08/12/26
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?Zacks Investment Research • 08/12/26
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?Zacks Investment Research • 08/12/26